Company: XAIR
Filing Date: 2025-01-31
Form Type: S-3
Source: 0001493152-25-004488
Chunk: 2

Company: Beyond Air, Inc.
Filing Date: 2025-01-31
Form: S-3
Chunk 2
---
 where such offer or sale is not permitted.

<div align='center'>SUBJECT TO COMPLETION, DATED JANUARY 31, 2025</div>

PROSPECTUS

<div align='center'>$200,000,000

Common Stock

Preferred Stock

Warrants

Debt Securities

Units</div>

We may offer to the public from time to time in one or more series or issuances:

| ● | shares of our common stock;                                  |
| ● | shares of our preferred                                      
 stock;                                                       |
| ● | warrants to purchase shares                                  
 of our common stock, preferred stock and/or debt securities; |
| ● | debt securities consisting                                   
 of debentures, notes or other evidences of indebtedness;     |
| ● | units consisting of a combination                            
 of the foregoing securities; or                              |
| ● | any combination of these                                     
 securities.                                                  |

The aggregate initial offering price of all securities sold by us pursuant to this prospectus will not exceed $200,000,000.

This prospectus provides a general description of the securities that we may offer. Each time that we offer securities under this prospectus, we will provide the specific terms of the securities offered, including the public offering price, in a supplement to this prospectus. Any prospectus supplement may add to, update or change information contained in this prospectus.

The securities may be sold by us to or through underwriters or dealers, directly to purchasers or through agents designated from time to time. For additional information on the methods of sale, you should refer to the section entitled “Plan of Distribution” in this prospectus and the comparable section of any applicable prospectus supplement. If any underwriters are involved in the sale of the securities with respect to which this prospectus is being delivered, the names of such underwriters and any applicable discounts or commissions and over-allotment options will be set forth in the applicable prospectus supplement.

Our common stock trades on the Nasdaq Capital Market under the ticker symbol “XAIR.” On January 30, 2025, the last reported sale price per share of our common stock was $0.38. We have not yet determined whether the other securities that may be offered by this prospectus will be listed on any exchange, interdealer quotation system or over-the-counter market. If we decide to seek the listing of any such securities upon issuance, the prospectus supplement relating to those securities will disclose the exchange, quotation system or market on which those securities will be